Background
Methods
Study population
Baseline variables
Diagnosis of NAFLD
Severity of acute coronary syndrome: GRACE score
Statistical analysis
Ethical approval
Results
Variable | NAFLD | Non- NAFLD | Total | Significance |
---|---|---|---|---|
n = 56 | n = 64 | n = 120 | ||
Age(years) | 62.9 ± 10.8 | 59.8 ± 12.6 | 61.28 ± 11.8 |
p = 0.157
|
Gender | ||||
Male | 30 (53.6) | 45 (70.3) | 75 (62.5) |
p = 0.059
|
Female | 26 (46.4) | 19 (29.7) | 45 (37.5) | |
Diabetes | 38 (67.9) | 32 (50.0) | 70 (58.3) |
p = 0.048
|
Hypertension | 44 (78.6) | 40 (62.5) | 84 (70.0) |
p = 0.055
|
Dyslipidaemia | 29 (51.8) | 21 (32.8) | 50 (41.7) |
p = 0.035
|
Smoking | 24 (42.9) | 31 (48.4) | 55 (45.8) |
p = 0.815
|
Alcohol consumption | ||||
Never | 33 (58.9) | 37 (57.8) | 70 (58.3) |
p = 0.902
|
< 20 g/day | 23 (41.1) | 27 (42.2) | 50 (41.7) | |
BMI | 24.59 ± 3.5 | 24.69 ± 12.9 | 24.64 ± 9.8 |
p = 0.958
|
Obesity (BMI > 27.5 kg/m2) | 12 (21.5) | 03 (4.7) | 15 (12.5) |
p = 0.005
|
Waist circumference | 101.2 ± 13.6 | 101.4 ± 17.3 | 101.3 ± 15.6 |
p = 0.941
|
Increase waist circumference a
| 48 (85.7) | 49 (76.6) | 97 (80.8) |
p = 0.204
|
FBS | 156.7 ± 72.9 | 134.7 ± 72.0 | 144.6 ± 72.9 |
p = 0.111
|
Total Cholesterol | 213.6 ± 40.3 | 189.3 ± 26.4 | 200.6 ± 35.6 |
p < 0.001
|
Triglyceride | 159.1 ± 46.4 | 122.2 ± 46.8 | 139.9 ± 49.9 |
p < 0.001
|
LDL-cholesterol | 148.2 ± 36.2 | 129.5 ± 24.2 | 138.6 ± 31.9 |
p = 0.005
|
ALT | 62.9 ± 46.2 | 29.4 ± 11.9 | 44.9 ± 36.5 |
p < 0.001
|
Type of ACS | ||||
STEMI | 16 (28.6) | 16 (25.0) | 32 (26.7) |
p = 0.659
|
Non-STEMI | 40 (71.4) | 48 (75.0) | 88 (73.3) |
ACS severity | NAFLD | Non-NAFLD | Total | Significance |
---|---|---|---|---|
n = 56 |
n = 64 |
n = 120 | ||
GRACE score Mean ± SD | 120.2 ± 26.9 | 92.3 ± 24.2 | 105.6 ± 29.0 |
p < 0.001
|
Predicted In-hospital mortality | ||||
Low risk | 22 (39.3) | 48 (75.0) | 70 (58.3) |
p < 0.001
|
Intermediate risk | 19 (33.9) | 9 (14.1) | 28 (23.3) | |
High risk | 12 (21.4) | 2 (3.1) | 14 (11.7) | |
Predicted post discharge mortality at 6 months | ||||
Low risk | 7 (12.5) | 28 (43.8) | 35 (29.2) |
p < 0.001
|
Intermediate risk | 21 (37.5) | 23 (35.9) | 44 (36.7) | |
High risk | 25 (44.6) | 8 (12.5) | 33 (27.5) |
Variable | OR (CI) | Significance | Adjusted OR (CI) | Significance |
---|---|---|---|---|
NAFLD | 6.15 (2.6–14.4) |
p < 0.001
| 31.3 (2.2–439.8) |
p = 0.011
|
Age | 1.15 (1.1–1.2) |
p < 0.001
| 1.32 (1.1–1.5) |
p = 0.001
|
Female gender | 8.77 (3.6–21.1) |
p < 0.001
| 2.94 (0.4–20.4) |
NS
|
Diabetes | 2.36 (1.04–5.3) |
p = 0.039
| 5.85 (0.6–53.6) |
NS
|
Hypertension | 3.14 (1.2–8.1) |
p = 0.017
| 1.35 (0.17–10.9) |
NS
|
Dyslipidaemia | 3.43 (1.5–7.6) |
p = 0.003
| 2.16 (0.3–14.5) |
NS
|
Smoking | 0.29 (0.13–0.67) |
p = 0.003
|
NS
| |
Obesity | 5.0 (1.4–17.2) |
p = 0.011
| 1.03 (0.1–10.5) |
NS
|
LDL | 1.02 (1.003–1.034) |
p = 0.017
| 1.01 (0.97–1.05) |
NS
|
ALT | 1.03 (1.01–1.05) |
p = 0.003
| 1.04 (0.98–1.09) |
NS
|
Waist circumference | 1.01 (0.9–1.04) |
p = 0.374
|
Variable | OR (CI) | Significance | Adjusted OR (CI) | Significance |
---|---|---|---|---|
NAFLD | 5.93 (2.3–15.3) |
p < 0.001
| 15.59 (1.6–130.6) |
p = 0.011
|
Age | 1.26 (1.2–1.4) |
p < 0.001
| 1.34 (1.1–1.5) |
p < 0.001
|
Female gender | 4.03 (1.5–10.8) |
p = 0.006
| 0.45 (0.07–3.1) |
NS
|
Diabetes | 1.32 (0.58–2.9) |
p = 0.501
| ||
Hypertension | 1.58 (0.7–3.7) |
p = 0.294
| ||
Dyslipidaemia | 2.19 (0.9–5.2) |
p = 0.073
| 2.08 (0.42–10.3) |
NS
|
Obesity | 7.49 (0.9–59.8) |
p = 0.057
| 0.56 (0.04–7.1) |
NS
|
LDL | 1.00 (0.9–1.02) |
p = 0.369
| ||
SGPT | 1.02 (1.00–1.05) |
p = 0.026
| 1.01 (0.9–1.09) |
NS
|
Waist circumference | 0.99 (0.96–1.02) |
p = 0.480
|